Yokota H, Tonami H
Department of Radiology, Kanazawa Medical University, Uchinada, Kahoku, Ishikawa, Japan.
Toxicol Ind Health. 2008 Apr;24(3):161-70. doi: 10.1177/0748233707078229.
Cadmium (Cd) has been identified as the etiologic agent of itai-itai disease. The purpose of this study was to investigate whether chronic Cd exposure affects bone metabolism in a male rat model and to estimate the bone mineral density (BMD) differences in lumbar and femoral bone because of Cd exposure. Six-week-old male Hos Donryu rats were used in this experiment. Cadmium was administered at a dose of 200 ppm to rats in the diet to produce experimental chronic Cd poisoning. Bone mineral density was measured using dual-energy X-ray absorptiometry (DEXA) with a high-resolution scan collimator (0.25 mm diameter) (Hologic QDR-2000). The Cd content in renal tissue reached a critical concentration of 128.42 +/- 14.38 microg/g 10 months after the administration of the element (Table 3). The average blood urea nitrogen (BUN) value was increased throughout the period of the experiment, and the serum creatinine value of the experimental group showed an increase after 2 months of Cd administration (0.46 +/- 0.09 mg/dL). The concentration of urinary calcium changed in the experimental group after exposure to Cd for 12 months (15.4 +/- 0.13 mg/dL). DEXA showed a greater reduction in the bone mineral density of the 5th vertebral body (L5) in rats that had ingested Cd for 4 months (0.359 +/- 0.013 g/cm2) than in control rats (0.372 +/- 0.012 g/cm2, P < 0.01). On the contrary, the difference in bone mineral content between rats ingesting Cd for 6-8 months and control rats was not significant. However, significant reductions in bone mineral content were again noted in rats that had ingested Cd for 12 months (0.339 +/- 0.023 g/cm2) compared with the control group (0.385 +/- 0.012 g/cm2, P < 0.01). The bone mineral density of the right femoral bone in control rats was 0.328 +/- 0.018 g/cm2 and that in experimental rats was 0.306 +/- 0.012 g/cm2, and a meaningful difference was recognized (P < 0.05). Histological examination of the rats exposed to Cd for 12 months showed that the 5th lumbar vertebral body (L5) exhibited osteomalacia. The results of our studies show that Cd stimulated a loss of bone mineral at an early stage to a great extent in male rats. In the examination of male rats, bone injury and renal functional disorder were encountered simultaneously. This study suggested that osteomalacia was induced by a direct action of Cd on the bone through abnormal calcium homeostasis at an early stage in male rats.
镉(Cd)已被确认为痛痛病的致病因子。本研究的目的是调查慢性镉暴露是否会影响雄性大鼠模型的骨代谢,并评估由于镉暴露导致的腰椎和股骨骨密度(BMD)差异。本实验使用6周龄的雄性Hos Donryu大鼠。在大鼠饮食中给予200 ppm剂量的镉以产生实验性慢性镉中毒。使用配备高分辨率扫描准直器(直径0.25 mm)的双能X线吸收法(DEXA)(Hologic QDR - 2000)测量骨密度。给予该元素10个月后,肾组织中的镉含量达到临界浓度128.42±14.38μg/g(表3)。在整个实验期间,平均血尿素氮(BUN)值升高,实验组的血清肌酐值在给予镉2个月后升高(0.46±0.09 mg/dL)。镉暴露12个月后,实验组尿钙浓度发生变化(15.4±0.13 mg/dL)。DEXA显示,摄入镉4个月的大鼠第五椎体(L5)的骨密度(0.359±0.013 g/cm²)比对照组大鼠(0.372±0.012 g/cm²,P < 0.01)降低得更多。相反,摄入镉6 - 8个月的大鼠与对照组大鼠之间的骨矿物质含量差异不显著。然而,与对照组(0.385±0.012 g/cm²,P < 0.01)相比,摄入镉12个月的大鼠骨矿物质含量再次显著降低(0.339±0.023 g/cm²)。对照组大鼠右股骨的骨密度为0.328±0.018 g/cm²,实验组大鼠为0.306±0.012 g/cm²,差异有统计学意义(P < 0.05)。对镉暴露12个月的大鼠进行组织学检查显示,第五腰椎椎体(L5)出现骨软化。我们的研究结果表明,镉在早期极大程度地刺激了雄性大鼠骨矿物质的流失。在对雄性大鼠的检查中,同时出现了骨损伤和肾功能障碍。本研究表明,在雄性大鼠早期,镉通过影响钙稳态异常直接作用于骨骼,从而诱发骨软化。